1. Home
  2. NTZ vs TLPH Comparison

NTZ vs TLPH Comparison

Compare NTZ & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natuzzi S.p.A.

NTZ

Natuzzi S.p.A.

HOLD

Current Price

$3.09

Market Cap

34.3M

ML Signal

HOLD

TLPH

Talphera Inc.

HOLD

Current Price

$0.78

Market Cap

37.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTZ
TLPH
Founded
1959
2005
Country
Italy
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.3M
37.9M
IPO Year
1998
2010

Fundamental Metrics

Financial Performance
Metric
NTZ
TLPH
Price
$3.09
$0.78
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
5.4K
211.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,151,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.15
$0.38
52 Week High
$5.50
$1.57

Technical Indicators

Market Signals
Indicator
NTZ
TLPH
Relative Strength Index (RSI) 46.42 38.74
Support Level $2.66 $0.76
Resistance Level $3.20 $0.79
Average True Range (ATR) 0.26 0.06
MACD -0.01 -0.01
Stochastic Oscillator 46.67 16.44

Price Performance

Historical Comparison
NTZ
TLPH

About NTZ Natuzzi S.p.A.

Natuzzi SpA is an Italian firm that designs, manufactures, and sells contemporary and traditional leather and fabric-upholstered furniture. Its product portfolio includes sofas, loveseats, armchairs, sectional furniture, motion furniture and sofa beds, living room furnishings, and accessories. The company markets its products under several brands such as Natuzzi Italia, Private label, and Natuzzi Editions. Geographically, it derives a majority of its revenue from the United States of America and also has an international presence in Italy, Spain, the UK, China, and Other countries.

About TLPH Talphera Inc.

Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.

Share on Social Networks: